Radiation therapy has emerged as a groundbreaking approach to boost the immune system’s ability to target and destroy cancer cells, particularly in cases where tumors display resistance to traditional immunotherapy.
Recent research conducted by experts at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Netherlands Cancer Institute has shed light on the molecular mechanisms underlying this phenomenon. By combining radiation therapy with immunotherapy, clinicians have observed a systemic anti-tumor immune response in non-small cell lung cancers that are typically unresponsive to immunotherapy alone. This innovative treatment approach has shown promising results in patients with tumors exhibiting features of immunotherapy resistance, offering new hope in the fight against cancer.
Read more from sciencedaily.com
